Transgenic Polyoma middle-T mice model premalignant mammary disease
J E Maglione1, D Moghanaki, L J Young
1Department of Medicine, Cancer Center, School of Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Cancer Research
|November 24, 2001
Summary
Polyomavirus middle T (PyV-mT) gene expression alone does not cause mammary tumors in mice. Additional events are necessary for malignant transformation, highlighting the multistep nature of tumorigenesis.
Area of Science:
- Oncology
- Genetics
- Mouse Models
Background:
- Polyomavirus middle T (PyV-mT) transgenic mice are crucial for mammary cancer research.
- Early events in mammary tumorigenesis and the potential of hyperplastic lesions remain understudied.
Purpose of the Study:
- To characterize PyV-mT-induced hyperplasias histopathologically.
- To assess the growth potential of these premalignant lesions through transplantation.
- To establish stable outgrowth lines for studying premalignant hyperplasia.
Main Methods:
- Comprehensive histopathological analysis of PyV-mT hyperplasias.
- Classical transplantation experiments to evaluate lesion growth potential.
- Establishment and characterization of stable hyperplastic outgrowth lines.
Main Results:
- PyV-mT hyperplasias exhibit heterogeneous malignant potential, indicated by varying tumor latencies.
- PyV-mT gene expression alone is insufficient for tumor induction.
- Additional molecular events are required for mammary tumorigenesis and metastasis.
Conclusions:
- PyV-mT transgenic mice provide a valuable model for studying multistep mammary tumorigenesis.
- Premalignant hyperplasias are heterogeneous and require further events for malignant progression.
- This study clarifies the role of PyV-mT in mammary cancer initiation.
